{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:11:09Z","timestamp":1792631469953,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.ijcard.2014.05.021","type":"journal-article","created":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T11:34:22Z","timestamp":1400240062000},"page":"30-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Current challenges for clinical trials of cardiovascular medical devices"],"prefix":"10.1016","volume":"175","author":[{"given":"Faiez","family":"Zannad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8290-1205","authenticated-orcid":false,"given":"Wendy Gattis","family":"Stough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana L.","family":"Pi\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano M.","family":"De Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Farb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Geller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Kieval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Linde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita F.","family":"Redberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alphons","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Woehrle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart J.","family":"Pocock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2014.05.021_bb0005","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0010","author":"U.S.Department of Health and Human Services"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/10543400701668225","article-title":"Statistics in the world of medical devices: the contrast with pharmaceuticals","volume":"18","author":"Campbell","year":"2008","journal-title":"J Biopharm Stat"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0020","series-title":"Cardiovascular therapeutics: a companion to Braunwald's heart disease","first-page":"41","article-title":"Device development for cardiovascular therapeutics: concepts and regulatory implications","author":"Schoen","year":"2013"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2013.284986","article-title":"FDA approval of cardiac implantable electronic devices via original and supplement premarket approval pathways, 1979\u20132012","volume":"311","author":"Rome","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0030","first-page":"35","article-title":"Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 trial","author":"Kandzari","year":"2012","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0035","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0040","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/eurjhf\/hft095","article-title":"Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document","volume":"15","author":"Zannad","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0045","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/clpt.2008.128","article-title":"The use of patient-reported outcome measures in the evaluation of medical products for regulatory approval","volume":"84","author":"Burke","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0050","author":"Committee for Medicinal Products for Human Use (CHMP)"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0055","author":"US Department of Health and Human Services Food and Drug Administration"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0060","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0140-6736(02)07816-9","article-title":"Blinding in randomised trials: hiding who got what","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0065","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.jacc.2012.08.1035","article-title":"Overview of the 2011 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee Meeting on the CardioMEMS Champion Heart Failure Monitoring System","volume":"61","author":"Loh","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0070","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0895-4356(00)00305-X","article-title":"Are randomized clinical trials good for us (in the short term)? Evidence for a \u201ctrial effect\u201d","volume":"54","author":"Braunholtz","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0075","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0080","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0085","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2008.08.027","article-title":"Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms","volume":"52","author":"Linde","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0090","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.athoracsur.2007.03.095","article-title":"Clinical evaluation of the CorCap cardiac support device in patients with dilated cardiomyopathy","volume":"84","author":"Mann","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0095","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMoa0708006","article-title":"Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia","volume":"358","author":"Wilde","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0100","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.athoracsur.2006.05.123","article-title":"Progress versus precision: challenges in clinical trial design for left ventricular assist devices","volume":"82","author":"Parides","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0105","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.athoracsur.2006.06.037","article-title":"Prosthetic heart valves: objective performance criteria versus randomized clinical trial","volume":"82","author":"Grunkemeier","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0110","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous-flow left ventricular assist device","volume":"361","author":"Slaughter","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0115","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Long-term use of a left ventricular assist device for end-stage heart failure","volume":"345","author":"Rose","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0120","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients","volume":"364","author":"Smith","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0125","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.athoracsur.2006.07.044","article-title":"FDA perspective on clinical trial design for cardiovascular devices","volume":"82","author":"Chen","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0130","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1161\/CIRCULATIONAHA.111.058412","article-title":"Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation","volume":"125","author":"Aaronson","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0135","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1161\/CIRCULATIONAHA.112.111948","article-title":"A bridge far enough?","volume":"125","author":"Stevenson","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0140","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.jvs.2009.10.041","article-title":"Premarket assessment of devices for treatment of critical limb ischemia: the role of objective performance criteria and goals","volume":"50","author":"Geraghty","year":"2009","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0145","author":"Food and Drug Administration"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0150","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/eurheartj\/ehs114","article-title":"Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes","volume":"33","author":"Dahabreh","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0155","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/Progestin Replacement Study (HERS) Research Group","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10543400601044691","article-title":"Statistical and regulatory issues with the application of propensity score analysis to nonrandomized medical device clinical studies","volume":"17","author":"Yue","year":"2007","journal-title":"J Biopharm Stat"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0165","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1001\/jama.2009.1899","article-title":"Strength of study evidence examined by the FDA in premarket approval of cardiovascular devices","volume":"302","author":"Dhruva","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0170","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1056\/NEJMe1202866","article-title":"Why we still need randomized trials to compare effectiveness","volume":"366","author":"Mauri","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0175","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/MJT.0b013e3182512ca5","article-title":"An analysis of implantable cardiac device reliability. The case for improved postmarketing risk assessment and surveillance","volume":"19","author":"Laskey","year":"2012","journal-title":"Am J Ther"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0180","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/CIRCOUTCOMES.111.962621","article-title":"Early detection of an underperforming implantable cardiovascular device using an automated safety surveillance tool","volume":"5","author":"Hauser","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0185","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.2010.1633","article-title":"Automated surveillance to detect postprocedure safety signals of approved cardiovascular devices","volume":"304","author":"Resnic","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0190","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMp0905338","article-title":"The new Sentinel Network\u2014improving the evidence of medical-product safety","volume":"361","author":"Platt","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0195","author":"U.S.Department of Health and Human Services"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0200","first-page":"58785","article-title":"Unique device identification system. Final rule","volume":"78","year":"2013","journal-title":"Fed Regist"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0205","doi-asserted-by":"crossref","DOI":"10.1001\/archinternmed.2011.247","article-title":"Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials","author":"Sipahi","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0210","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/eurheartj\/ehs107","article-title":"Multidisciplinary care of patients receiving cardiac resynchronization therapy is associated with improved clinical outcomes","volume":"33","author":"Altman","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0215","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/eurheartj\/ehr171","article-title":"Clinical evaluation of cardiovascular devices: principles, problems, and proposals for European regulatory reform. Report of a policy conference of the European Society of Cardiology","volume":"32","author":"Fraser","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0220","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMp1109150","article-title":"Medical devices and health\u2014creating a new regulatory framework for moderate-risk devices","volume":"365","author":"Challoner","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0225","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJMhle1113918","article-title":"Regulation of medical devices in the United States and European Union","volume":"366","author":"Kramer","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0230","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/archinternmed.2011.329","article-title":"Medical device regulatory reform: insights from the watchman left atrial appendage closure technology for stroke prophylaxis in atrial fibrillation","volume":"171","author":"Cingolani","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0235","series-title":"Medical devices and the public's health: the FDA 510(k) clearance process at 35years","author":"Institute of Medicine","year":"2011"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0240","doi-asserted-by":"crossref","first-page":"d2973","DOI":"10.1136\/bmj.d2973","article-title":"Medical device recalls and transparency in the UK","volume":"342","author":"Thompson","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0245","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMp1109094","article-title":"Medical devices\u2014balancing regulation and innovation","volume":"365","author":"Curfman","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2014.05.021_bb0250","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1056\/NEJMc1113164","article-title":"Medical devices\u2014balancing regulation and innovation","volume":"366","author":"Feder","year":"2012","journal-title":"N Engl J Med"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314010043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314010043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:35:05Z","timestamp":1759091705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527314010043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0167527314010043"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.05.021","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current challenges for clinical trials of cardiovascular medical devices","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}